This white paper will explore how COVID-19 pushed the industry to adapt to tech-enabled solutions for patients and sponsors.

Key takeaways include:

  • The importance of decentralized/hybrid trial models and remote monitoring in current and future studies.
  • What regulatory changes were brought into effect during the pandemic that will change the future of research.
  • How innovations in technology were used to support clinical research during the pandemic in order to keep trials on track and make future trials more efficient.


When you need direct access to physicians and their known patients or research practice management solutions to accelerate your clinical trials, there’s Only Elligo.

Contact Us